Home › NDC Lookup › RxCUI directory › RxCUI 2700404

0.5 ML ustekinumab-stba 90 MG/ML Prefilled Syringe — RxCUI 2700404

Name: 0.5 ML ustekinumab-stba 90 MG/ML Prefilled Syringe (RxCUI 2700404)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2700404 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2700404

Official name0.5 ML ustekinumab-stba 90 MG/ML Prefilled Syringe

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asustekinumab-stba 45 MG per 0.5 ML Prefilled Syringe; ustekinumab-stba 45 MG in 0.5 ML Prefilled Syringe; ustekinumab-stba 90 MG/ML per 0.5 ML Prefilled Syringe

FDA products mapped4

Package NDCs mapped4

Reported Medicaid activity (SDUD)282 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ustekinumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Ustekinumab is approved to treat moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohn's disease, and moderately to severely active u...
What conditions does ustekinumab treat, and is it right for me?
It depends on your condition. For Crohn's disease and ulcerative colitis, the first dose is given as an IV infusion in a clinical setting. After that, you switch to under-the-skin...
How is ustekinumab given, and will I need to go to a clinic every time?

📖 Read our full Ustekinumab Injection guide →

🕸️ Concept Web — How 0.5 ML ustekinumab-stba 90 MG/ML Prefilled Syrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.5 ML ustekinumab-stba 90 MG/ML Prefilled Syringe RxCUI 2700404 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Ustekinumab 847083 IN
- Ustekinumab-stba 2700389 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Steqeyma 2700395 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Ustekinumab Prefilled Syringe 853349 SCDF
- Ustekinumab-stba Prefilled Syringe 2700403 SCDFP
- Ustekinumab Injectable Product 1163983 SCDG
- Ustekinumab-stba Injectable Product 2700391 SCDGP
- Ustekinumab Prefilled Syringe [Steqeyma] 2700407 SBDF
- Ustekinumab-stba Prefilled Syringe [Steqeyma] 2700408 SBDFP
- Steqeyma Injectable Product 2700397 SBDG
- Prefilled Syringe 721656 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Ustekinumab-stba 90 MG/ML 2700402 SCDC
- 0.5 ML ustekinumab-stba 90 MG/ML Prefilled Syringe [Steqeyma] 2700409 SBD
- Ustekinumab-stba 90 MG/ML [Steqeyma] 2700406 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Ustekinumab-stba 90 MG/ML SCDC · 2700402
Ustekinumab Prefilled Syringe SCDF · 853349
Ustekinumab-stba Prefilled Syringe SCDFP · 2700403
Ustekinumab Injectable Product SCDG · 1163983
Ustekinumab-stba Injectable Product SCDGP · 2700391

Brand-Name Concepts

0.5 ML ustekinumab-stba 90 MG/ML Prefilled Syringe [Steqeyma] SBD · 2700409
Ustekinumab-stba 90 MG/ML [Steqeyma] SBDC · 2700406
Ustekinumab Prefilled Syringe [Steqeyma] SBDF · 2700407
Ustekinumab-stba Prefilled Syringe [Steqeyma] SBDFP · 2700408
Steqeyma Injectable Product SBDG · 2700397
Steqeyma BN · 2700395

📦 FDA Products & Package NDCs

4 products · 4 package NDCs

4 package NDCs map to RxCUI 2700404 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
72606-0027-01	1 SYRINGE in 1 CARTON (72606-027-01) / .5 mL in 1 SYRINGE	STEQEYMA	CELLTRION USA, Inc.	2025-03-12
72606-0028-01	1 SYRINGE in 1 CARTON (72606-028-01) / 1 mL in 1 SYRINGE	STEQEYMA	CELLTRION USA, Inc.	2025-03-12
72606-0029-01	1 VIAL, SINGLE-USE in 1 CARTON (72606-029-01) / 26 mL in 1...	STEQEYMA	CELLTRION USA, Inc.	2025-03-12
72606-0060-01	1 VIAL, SINGLE-DOSE in 1 CARTON (72606-060-01) / .5 mL in 1...	STEQEYMA	CELLTRION USA, Inc.	2026-04-13

Observed labelers: CELLTRION USA, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
Q5099	Inj ustekinumab-stba, 1 mg	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.